Westchester Capital Management (New York)’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Westchester Capital Management (New York)’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-127,876	Closed	-$12.4M	–	184
2019 Q3	$12.4M	Sell	127,876 -115,003	-47%	-$11.5M	0.48%	36
2019 Q2	$24.9M	Buy	+242,879	New	+$26.2M	0.81%	21

Westchester Capital Management (New York)'s ONCE Position: Q4 2019 in Review

Westchester Capital Management (New York) sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 127,876 shares — an estimated $12.4M sold.

Westchester Capital Management (New York) first reported a position in ONCE in Q2 2019 and held it in 2 quarters. The position peaked at $24.9M in Q2 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Westchester Capital Management (New York) reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Westchester Capital Management (New York) sold 127,876 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $12.4M.
Westchester Capital Management (New York) first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2019 and held it in 2 quarters.
Westchester Capital Management (New York)'s Spark Therapeutics, Inc. Common Stock position peaked at $24.9M in Q2 2019.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Westchester Capital Management (New York)'s 13F filing for Q4 2019, filed 14 Feb 2020.